piperazine citrate (Antepar)

07/01/1979 - " In a double blind trial, 13 boys with the infection were given piperazine citrate or a placebo syrup. "
03/25/2008 - "Following a 3-month observation period, all animals of the three groups were treated with piperazine citrate to eliminate intestinal infections and all were administered 100 embryonated eggs. "
06/15/1959 - "An evaluation of piperazine citrate for preventing prenatal infections with the common dog ascarid (Toxocara canis)."
11/01/1955 - "Treatment of multiple intestinal worm infections with piperazine citrate."
07/01/1955 - "[Infections by Ascaris lumbricoides in children treated with piperazine citrate]."

03/01/2012 - "The effect of piperazine citrate on the electrocardiogram of the rat after treatment with piperazine citrate at 30, 60, and 100 mg/kg body weight for 16 weeks was investigated. "
08/01/2015 - "The anthelmintic treatment (piperazine citrate) was administered at 1 g per kg body weight. "
03/01/2008 - "Fifteen of 20 Wistar albino rats were treated with various doses of the anthelmintic agent piperazine citrate (15, 30, and 60 mg/kg body weight). "
03/01/1981 - "Pyrantel pamoate at a dose of 10 mg/kg body weight daily for 2 or 3 days was found to be more effective against Ascaris than both a regimen of bephenium hydroxynaphthoate (2.5 g base) and piperazine citrate (2-3 g) given daily for 2 days and a placebo-treated control group. "
04/01/1985 - "The effect of pretreatment with lignocaine hydrochloride (0.1 mg/g body weight) and piperazine citrate (1 mg/g body weight) on the number of deaths due to ouabain (0.02-0.12 mg/g body weight) was determined in the toad. "

07/01/1966 - "Single-dose treatment for Ascaris infection with piperazine citrate; with a study of the egg-parasite ratio."
09/01/1977 - "Control of ascariasis by mass treatment with piperazine citrate."
01/01/1957 - "On the single-dose treatment of ascariasis with piperazine citrate."
12/15/1956 - "[Piperazine citrate in the management of ascariasis]."
09/01/1956 - "Mass treatment of ascariasis with a single dose of piperazine citrate."

01/01/2021 - "At a concentration of 10 mg/ml, paralysis and death time for CAEE was recorded as (10.08 ± 1.11) and (65.28 ± 2.09) respectively, while for standard piperazine citrate, it was recorded as (22.96 ± 1.12) and (65.09 ± 1.23). "
01/01/2011 - "The time of paralysis and time of death were studied and the activity was compared with piperazine citrate as reference standard. "
06/01/2010 - "Test results revealed that compounds showed paralysis time of 0.24 to 1.54 min and death time of 0.39 to 4.40 min while the standard drugs albendazole and piperazine citrate showed paralysis time of 0.54 and 0.58 min and death time of 2.16 and 2.47 min, respectively, at the same concentration of 1% (m/V). "
02/01/2013 - "Analogs 5a, 5c, 5g and 5h showed promising anthelmintic activity against Eisemia foetida in a low concentration as compared to standard drug piperazine citrate with mean paralysis time ranging 22.60 ± 2.46 to 31.60 ± 3.07 min. All synthesized compounds depicted good in vivo analgesic activity with compound 5a exhibiting the most potent activity of 55.19% inhibition of writhing in comparison to the standard drug."

01/01/1962 - "[Results of the treatment of oxyuriasis with Adipinian and piperazine citrate in children's homes in Gdansk and Sopot]."
09/02/1955 - "[Piperazine citrate for treatment of oxyuriasis]."
06/01/1955 - "Oxyuriasis: incidence in two socioeconomic groups of negro children; use of piperazine citrate in therapy."